Research Highlights: In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by...
Don’t want to stop being cruel and violent? Want to keep committing atrocity against vulnerable individuals while destroying human-supporting environments on Earth, for absolutely no practical benefit to yourself? Well good news! Investor-driven medical research is here to protect you (and only you) from the consequences of your monstrous choices!
Don’t want to stop being cruel and violent? Want to keep committing atrocity against vulnerable individuals while destroying human-supporting environments on Earth, for absolutely no practical benefit to yourself? Well good news! Investor-driven medical research is here to protect you (and only you) from the consequences of your monstrous choices!
What are you talking about?